Literature DB >> 25862376

Four FCRL3 Gene Polymorphisms (FCRL3_3, _5, _6, _8) Confer Susceptibility to Multiple Sclerosis: Results from a Case-Control Study.

Menghui Yuan1, Longxiao Wei2, Runsuo Zhou1, Qianrong Bai1, Yixin Wei1, Wei Zhang1, Yong Huang1.   

Abstract

Multiple sclerosis (MS) is an autoimmune/inflammatory neurodegenerative disease which mainly affects the central nervous system in young adults. Fc-receptor-like-3 (FCRL3) gene, which involved in immune cell regulation, has drawn lots of attentions. This study aims to investigate the association between common polymorphisms of FCRL3 gene and MS risk in a Chinese Han population. Nine single nucleotide polymorphisms (SNPs) were genotyped in 120 patients and 240 healthy controls through PCR assay. t test and chi-square test was conducted to find a possible association between FCRL3 genetic mutations and risk of MS. This analysis results performed that four SNPs, rs7528684 (FCRL3_3), rs945635 (FCRL3_5), rs3761959 (FCRL3_6), and rs2282284 (FCRL3_8), were significantly associated with the risk of MS. Further haplotype analysis showed two haplotypes of FCRL3_3, 5, 6, 8, CCAG and CGAG, presented the significant associations with the susceptibility to MS. Four SNPs in FCRL3 gene could possibly associate with the susceptibility of MS in a Chinese Han population. Moreover, the haplotype analysis confirmed that the linkage disequilibrium exists in polymorphisms in FCRL3. Based on the supporting evidence, we deduced that FCRL3_3C, FCRL3_5C, FCRL3_6A, and FCRL3_8G caused increased risk of MS. Nevertheless, large cohort studies are required in the future to validate the autoimmune function.

Entities:  

Keywords:  FCRL3 gene; Haplotype; Multiple sclerosis; Single-nucleotide polymorphisms

Mesh:

Substances:

Year:  2015        PMID: 25862376     DOI: 10.1007/s12035-015-9149-7

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  33 in total

1.  Genetic association of Fc receptor-like 3 polymorphisms with autoimmune pancreatitis in Japanese patients.

Authors:  T Umemura; M Ota; H Hamano; Y Katsuyama; K Kiyosawa; S Kawa
Journal:  Gut       Date:  2006-09       Impact factor: 23.059

2.  Polymorphisms of the FCRL3 gene in a Spanish population of systemic lupus erythematosus patients.

Authors:  E Sanchez; J L Callejas; J M Sabio; M de Haro; M Camps; E de Ramón; F J García-Hernández; B Koeleman; J Martín; M F González-Escribano
Journal:  Rheumatology (Oxford)       Date:  2006-05-22       Impact factor: 7.580

Review 3.  IgG Fc receptors.

Authors:  J V Ravetch; S Bolland
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

4.  Supportive evidence for a genetic association of the FCRL3 promoter polymorphism with rheumatoid arthritis.

Authors:  K Ikari; S Momohara; T Nakamura; M Hara; H Yamanaka; T Tomatsu; N Kamatani
Journal:  Ann Rheum Dis       Date:  2005-09-21       Impact factor: 19.103

5.  A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities.

Authors:  Yuta Kochi; Ryo Yamada; Akari Suzuki; John B Harley; Senji Shirasawa; Tetsuji Sawada; Sang-Cheol Bae; Shinya Tokuhiro; Xiaotian Chang; Akihiro Sekine; Atsushi Takahashi; Tatsuhiko Tsunoda; Yozo Ohnishi; Kenneth M Kaufman; Changsoo Paul Kang; Changwon Kang; Shigeru Otsubo; Wako Yumura; Akio Mimori; Takao Koike; Yusuke Nakamura; Takehiko Sasazuki; Kazuhiko Yamamoto
Journal:  Nat Genet       Date:  2005-04-17       Impact factor: 38.330

6.  Expression of the autoimmune susceptibility gene FcRL3 on human regulatory T cells is associated with dysfunction and high levels of programmed cell death-1.

Authors:  Louise A Swainson; Jeff E Mold; Urmila D Bajpai; Joseph M McCune
Journal:  J Immunol       Date:  2010-02-26       Impact factor: 5.422

7.  Contribution of single nucleotide polymorphisms within FCRL3 and MAP3K7IP2 to the pathogenesis of Graves' disease.

Authors:  M J Simmonds; J M Heward; J Carr-Smith; H Foxall; J A Franklyn; S C L Gough
Journal:  J Clin Endocrinol Metab       Date:  2005-12-29       Impact factor: 5.958

8.  FCRL3 -169CT functional polymorphism in type 1 diabetes and autoimmunity traits.

Authors:  Sabine Duchatelet; Sophie Caillat-Zucman; Danièle Dubois-Laforgue; Hervé Blanc; José Timsit; Cécile Julier
Journal:  Biomed Pharmacother       Date:  2007-10-08       Impact factor: 6.529

9.  Analysis of the Fc receptor-like-3 (FCRL3) locus in Caucasians with autoimmune disorders suggests a complex pattern of disease association.

Authors:  Catherine J Owen; Hannah Kelly; James A Eden; Marilyn E Merriman; Simon H S Pearce; Tony R Merriman
Journal:  J Clin Endocrinol Metab       Date:  2007-01-02       Impact factor: 5.958

10.  Association of the FCRL3 gene with rheumatoid arthritis: a further example of population specificity?

Authors:  Stephen Eyre; John Bowes; Catherine Potter; Jane Worthington; Anne Barton
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

View more
  4 in total

Review 1.  Immunogenetics of autoimmune thyroid diseases: A comprehensive review.

Authors:  Hanna J Lee; Cheuk Wun Li; Sara Salehi Hammerstad; Mihaela Stefan; Yaron Tomer
Journal:  J Autoimmun       Date:  2015-07-30       Impact factor: 7.094

2.  Genomic determinants of long-term cardiometabolic complications in childhood acute lymphoblastic leukemia survivors.

Authors:  Jade England; Simon Drouin; Patrick Beaulieu; Pascal St-Onge; Maja Krajinovic; Caroline Laverdière; Emile Levy; Valérie Marcil; Daniel Sinnett
Journal:  BMC Cancer       Date:  2017-11-10       Impact factor: 4.430

3.  Single Nucleotide Polymorphisms of FCRL3 in Iranian Patients with Behcet's Disease.

Authors:  Farhad Shahram; Javad Kazemi; Mahmoud Mahmoudi; Zohreh Jadali
Journal:  Iran J Public Health       Date:  2019-06       Impact factor: 1.429

4.  Fc receptor-like 3 (-169T>C) polymorphism increases the risk of tendinopathy in volleyball athletes: a case control study.

Authors:  José Inácio Salles; Lucas Rafael Lopes; Maria Eugenia Leite Duarte; Dylan Morrissey; Marilena Bezerra Martins; Daniel Escorsim Machado; João Antonio Matheus Guimarães; Jamila Alessandra Perini
Journal:  BMC Med Genet       Date:  2018-07-18       Impact factor: 2.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.